HRMY
Harmony Biosciences Holdings Inc.
$30.09
-$0.06(-0.20%)
53
Overall
80
Value
27
Tech
52
Quality
Market Cap
$1.49B
Volume
691.90K
52W Range
$25.52 - $40.87
Target Price
$44.36
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $159.7M | $305.4M | $437.9M | $582.0M | $714.7M | $868.5M | ||
| Total Revenue | $159.7M | $305.4M | $437.9M | $582.0M | $714.7M | $868.5M | ||
| COST OF GOODS SOLD | ||||||||
| Cost of Revenue | $27.7M | $55.5M | $83.5M | $121.2M | $156.8M | $198.3M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $132.0M | $249.9M | $354.4M | $460.8M | $557.9M | $670.1M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $115.0M | $162.4M | $234.2M | $268.8M | $367.1M | $461.6M | ||
| Research & Development | $19.4M | $30.4M | $70.9M | $76.1M | $145.8M | $189.6M | ||
| Research Expense | $19.4M | $30.4M | $70.9M | $76.1M | $145.8M | $189.6M | ||
| Selling, General & Administrative | $95.6M | $132.0M | $163.3M | $192.7M | $221.3M | $272.0M | ||
| Selling & Marketing Expenses | $55.8M | $68.1M | $79.3M | $97.4M | $110.9M | $119.5M | ||
| General & Administrative Expenses | $39.7M | $63.9M | $84.0M | $95.3M | $110.4M | $152.5M | ||
| Promotion & Advertising | $13.3M | $19.6M | $22.4M | -- | -- | -- | ||
| Salaries & Wages | $4.7M | $15.7M | $26.9M | $31.2M | $42.7M | $45.0M | ||
| Amortization | $164.8M | $146.2M | $162.6M | $140.4M | $114.0M | -- | ||
| Other Operating Expenses | $686.0K | $1.2M | $1.5M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||
| Operating income | $17.0M | $87.5M | $120.2M | $192.0M | $190.8M | $208.5M | ||
| EBITDA | $1.5M | $80.5M | $123.5M | $221.5M | $233.1M | $253.6M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $28.2M | $24.2M | $18.8M | $23.8M | $17.5M | $14.6M | ||
| Intinc | $-28.2M | $-24.0M | $-15.7M | $14.7M | $18.5M | -- | ||
| Net Non-Operating Interest Income/Expense | $-28.2M | $-24.0M | $15.7M | $-9.0M | $-17.5M | $-14.6M | ||
| Gain on Sale of Securities | -- | -- | $3.1M | -- | $18.5M | $21.9M | ||
| Other Income/Expense | $25.7M | $26.1M | $169.0K | $-5.1M | $-18.5M | $-21.2M | ||
| Other Special Charges | $-25.7M | $-26.1M | $169.0K | $-9.6M | $-68.0K | $-680.0K | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-8.7M | $61.6M | $123.5M | $197.2M | $209.3M | $229.7M | ||
| Pre-Tax Income | $-36.9M | $37.4M | $104.7M | $173.4M | $191.8M | $215.1M | ||
| INCOME TAX | ||||||||
| Tax Provision | $-6.4M | $2.8M | $-76.8M | $44.5M | $46.3M | $56.4M | ||
| NET INCOME | ||||||||
| Net Income | $-36.9M | $34.6M | $181.5M | $128.9M | $145.5M | $158.7M | ||
| Net Income (Continuing Operations) | $-36.9M | $34.6M | $181.5M | $128.9M | $145.5M | $158.7M | ||
| Net Income (Discontinued Operations) | $-36.9M | $34.6M | $181.5M | $128.9M | $145.5M | $158.7M | ||
| Net Income (Common Stockholders) | $-63.8M | $34.6M | $181.5M | $128.9M | $145.5M | $158.7M | ||
| Normalized Income | -- | -- | -- | -- | -- | $212.9M | ||
| TOTALS | ||||||||
| Total Expenses | $142.8M | $217.9M | $317.7M | $390.0M | $523.9M | $660.0M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $25.8M | $57.5M | $59.2M | $59.5M | $56.9M | $57.5M | ||
| Average Shares Outstanding (Diluted) | $25.8M | $59.2M | $61.1M | $60.4M | $57.9M | $58.5M | ||
| Shares Outstanding | $56.9M | $58.9M | $59.6M | $56.8M | $57.3M | $57.8M | ||
| Basic EPS | $-2.48 | $0.60 | $3.07 | $2.17 | $2.56 | $2.76 | ||
| Basic EPS (Continuing Operations) | $-2.48 | $0.60 | $3.07 | $2.17 | $2.56 | $2.76 | ||
| Diluted EPS | $-2.48 | $0.58 | $2.97 | $2.13 | $2.51 | $2.71 | ||
| Diluted EPS (Continuing Operations) | $-2.48 | $0.58 | $2.97 | $2.13 | $2.51 | $2.71 | ||
| OTHER METRICS | ||||||||
| Accrued Preferred Stock Dividends | $26.9M | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | $26.2M | $22.0M | -- | -- | -- | -- | ||
| Other Gand A | $39.7M | $63.9M | $84.0M | $95.3M | $110.4M | $152.5M | ||
| Preferred Stock Dividends | $26.9M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HRMY | $30.09 | -0.2% | 691.90K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Harmony Biosciences Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW